Literature DB >> 9316753

Pneumothorax and pneumomediastinum after laparoscopic surgery.

H M Richard1, A Stancato-Pasik, B A Salky, D S Mendelson.   

Abstract

Pneumothorax, pneumomediastinum, pneumopericardium, and subcutaneous emphysema have been described as complications of laparoscopy. This study evaluates the incidence and significance of these extra alveolar collections of air. We found that pneumomediastinum with or without pneumothorax was not associated with significant morbidity and is more likely after laparoscopic fundoplication than other laparoscopic surgeries. The presence of pneumomediastinum after fundoplication is a normal finding. However, pneumothorax has clinical significance and should be considered pathological.

Entities:  

Mesh:

Year:  1997        PMID: 9316753     DOI: 10.1016/s0899-7071(96)00086-1

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  5 in total

1.  Symptomatic Pneumomediastinum Following Laparoscopic Cholecystectomy: A Case Report and a Literature Review.

Authors:  Hani H Maalouf; Ribal Aby Hadeer; Omar Tabbikha; Christina Abou-Malhab; Raja Wakim
Journal:  Cureus       Date:  2022-04-29

Review 2.  Subcutaneous emphysema--beyond the pneumoperitoneum.

Authors:  Douglas E Ott
Journal:  JSLS       Date:  2014 Jan-Mar       Impact factor: 2.172

3.  Pneumomediastinum as a complication of preperitoneal laparoscopic herniorrhaphy.

Authors:  Atul K Madan; Maggie Likes; Aml Raafat
Journal:  JSLS       Date:  2003 Jan-Mar       Impact factor: 2.172

4.  Use of intraoperative ultrasonography for identification and management of pneumothorax caused by iatrogenic diaphragm defect: a case report and literature review.

Authors:  Qiang Han; Beibei Wang; Aijun Xu
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

Review 5.  Spontaneous hemopneumothorax after laparoscopy: a case report and literature review.

Authors:  Zhenyan Gao; Qing Wang; Juntao Shi; Huihua Cao; Yugang Wu; Qicheng Lu
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.573

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.